Cargando…

Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells

The major problem in stem cell therapy includes viability and engraftment efficacy of stem cells after transplantation. Indeed, the vast majority of host-transfused cells do not survive beyond 24–72 hrs. To increase the survival and engraftment of implanted cardiac stem cells in the host, we develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorbunov, Nikolai, Petrovski, Goran, Gurusamy, Narasimman, Ray, Diptarka, Kim, Do Han, Das, Dipak K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823103/
https://www.ncbi.nlm.nih.gov/pubmed/21352470
http://dx.doi.org/10.1111/j.1582-4934.2011.01281.x
_version_ 1782290509919682560
author Gorbunov, Nikolai
Petrovski, Goran
Gurusamy, Narasimman
Ray, Diptarka
Kim, Do Han
Das, Dipak K
author_facet Gorbunov, Nikolai
Petrovski, Goran
Gurusamy, Narasimman
Ray, Diptarka
Kim, Do Han
Das, Dipak K
author_sort Gorbunov, Nikolai
collection PubMed
description The major problem in stem cell therapy includes viability and engraftment efficacy of stem cells after transplantation. Indeed, the vast majority of host-transfused cells do not survive beyond 24–72 hrs. To increase the survival and engraftment of implanted cardiac stem cells in the host, we developed a technique of treating these cells with resveratrol, and tested it in a rat model of left anterior descending (LAD) occlusion. Multi-potent clonogenic cardiac stem cells isolated from rat heart and stably transfected with EGFP were pre-treated with 2.5 μM resveratrol for 60 min. Rats were anaesthetized, hearts opened and the LAD occluded to induce heart attack. One week later, the cardiac reduced environment was confirmed in resveratrol treated rat hearts by the enhanced expression of nuclear factor-E2-related factor-2 (Nrf2) and redox effector factor-1 (Ref-1). M-mode echocardiography after stem cell therapy, showed improvement in cardiac function (left ventricular ejection fraction, fractional shortening and cardiac output) in both, the treated and control group after 7 days, but only resveratrol-modified stem cell group revealed improvement in cardiac function at the end of 1, 2 and 4 months time. The improvement of cardiac function was accompanied by enhanced stem cell survival and engraftment as demonstrated by the expression of cell proliferation marker Ki67 and differentiation of stem cells towards the regeneration of the myocardium as demonstrated by the expression of EGFP up to 4 months after LAD occlusion in the resveratrol-treated stem cell group. Expression of stromal cell-derived factor and myosin conclusively demonstrated homing of stem cells in the infarcted myocardium, its regeneration leading to improvement of cardiac function.
format Online
Article
Text
id pubmed-3823103
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-38231032015-03-27 Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells Gorbunov, Nikolai Petrovski, Goran Gurusamy, Narasimman Ray, Diptarka Kim, Do Han Das, Dipak K J Cell Mol Med Original Articles The major problem in stem cell therapy includes viability and engraftment efficacy of stem cells after transplantation. Indeed, the vast majority of host-transfused cells do not survive beyond 24–72 hrs. To increase the survival and engraftment of implanted cardiac stem cells in the host, we developed a technique of treating these cells with resveratrol, and tested it in a rat model of left anterior descending (LAD) occlusion. Multi-potent clonogenic cardiac stem cells isolated from rat heart and stably transfected with EGFP were pre-treated with 2.5 μM resveratrol for 60 min. Rats were anaesthetized, hearts opened and the LAD occluded to induce heart attack. One week later, the cardiac reduced environment was confirmed in resveratrol treated rat hearts by the enhanced expression of nuclear factor-E2-related factor-2 (Nrf2) and redox effector factor-1 (Ref-1). M-mode echocardiography after stem cell therapy, showed improvement in cardiac function (left ventricular ejection fraction, fractional shortening and cardiac output) in both, the treated and control group after 7 days, but only resveratrol-modified stem cell group revealed improvement in cardiac function at the end of 1, 2 and 4 months time. The improvement of cardiac function was accompanied by enhanced stem cell survival and engraftment as demonstrated by the expression of cell proliferation marker Ki67 and differentiation of stem cells towards the regeneration of the myocardium as demonstrated by the expression of EGFP up to 4 months after LAD occlusion in the resveratrol-treated stem cell group. Expression of stromal cell-derived factor and myosin conclusively demonstrated homing of stem cells in the infarcted myocardium, its regeneration leading to improvement of cardiac function. Blackwell Publishing Ltd 2012-01 2011-12-29 /pmc/articles/PMC3823103/ /pubmed/21352470 http://dx.doi.org/10.1111/j.1582-4934.2011.01281.x Text en © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
spellingShingle Original Articles
Gorbunov, Nikolai
Petrovski, Goran
Gurusamy, Narasimman
Ray, Diptarka
Kim, Do Han
Das, Dipak K
Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
title Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
title_full Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
title_fullStr Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
title_full_unstemmed Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
title_short Regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
title_sort regeneration of infarcted myocardium with resveratrol-modified cardiac stem cells
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823103/
https://www.ncbi.nlm.nih.gov/pubmed/21352470
http://dx.doi.org/10.1111/j.1582-4934.2011.01281.x
work_keys_str_mv AT gorbunovnikolai regenerationofinfarctedmyocardiumwithresveratrolmodifiedcardiacstemcells
AT petrovskigoran regenerationofinfarctedmyocardiumwithresveratrolmodifiedcardiacstemcells
AT gurusamynarasimman regenerationofinfarctedmyocardiumwithresveratrolmodifiedcardiacstemcells
AT raydiptarka regenerationofinfarctedmyocardiumwithresveratrolmodifiedcardiacstemcells
AT kimdohan regenerationofinfarctedmyocardiumwithresveratrolmodifiedcardiacstemcells
AT dasdipakk regenerationofinfarctedmyocardiumwithresveratrolmodifiedcardiacstemcells